WHO ICTRP trial

Botulinum toxin type A (AGN-151607) for the prevention of post operative atrial…

EUCTR2017-004399-68-GB · EU Clinical Trials Register · Authorised

Key facts

Trial ID EUCTR2017-004399-68-GB
Public title Botulinum toxin type A (AGN-151607) for the prevention of post operative atrial fibrillation in patients undergoing open-chest cardiac surgery
Scientific title A Phase 2, Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Dose Ranging Study to Evaluate the Efficacy and Safety of Botulinum Toxin Type A (AGN 151607) Injections into the Epicardial Fat Pads to Prevent Post-Operative Atrial Fibrillation in Patients Undergoing Open-Chest Cardiac Surgery
Primary sponsor Allergan Ltd.
Registry EU Clinical Trials Register
Recruitment status Authorised
Study type Interventional clinical trial of medicinal product
Phase Human pharmacology (Phase I): no Therapeutic exploratory (Phase II): yes Therapeutic confirmatory - (Phase III): no Therapeutic use (Phase IV): no
Countries United States;Canada;Spain;Austria;Russian Federation;Netherlands;Germany;Italy;United Kingdom;Sweden
Conditions Post-operative atrial fibrillation (POAF) MedDRA version: 20.0 Level: PT Classification code 10003658 Term: Atrial fibrillation System Organ Class: 10007541 - Cardiac disorders ;Therapeutic area: Diseases [C] - Cardiovascular Diseases [C14]
Interventions Product Name: Clostridium botulinum neurotoxin type A (BoNT/A) complex Product Code: AGN-151607 Pharmaceutical Form: Lyophilisate for solution for injection INN or Proposed INN: NA CAS Number: 1883793-14-3 Current Sponsor code: AGN-151607…
Registration date Sep 20, 2018
Target size 330
Secondary IDs 1925-201-008;135000
Registry page clinicaltrialsregister.eu

At a glance

  • No Results available

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About WHO ICTRP trial registrations

The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.

Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date:

Browse all WHO ICTRP trial registrations